Business Description
Minerva Neurosciences is a Massachusetts-based drug development company founded in 2007 that specializes in treating brain and nervous system disorders. The company's primary focus is roluperidone, a drug currently in late-stage clinical testing aimed at relieving certain persistent symptoms experienced by people living with schizophrenia.
